WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 561454
Description: SXT1596 is a novel inhibitor of the SS18-SSX/TLE1 interaction. SXT1596 decreases cell viability and reactivates EGR1 expression in synovial sarcoma.
MedKoo Cat#: 561454
Chemical Formula: C10H9NO4
Exact Mass: 207.0532
Molecular Weight: 207.19
Elemental Analysis: C, 57.97; H, 4.38; N, 6.76; O, 30.89
Synonym: NSC65667; NSC-65667; NSC 65667; SXT1596; SXT-1596; SXT 1596;
IUPAC/Chemical Name: 5-(2-Nitro-1-propenyl)-1,3-benzodioxole
InChi Key: CCEVJKZHAJJQJR-QPJJXVBHSA-N
InChi Code: InChI=1S/C10H9NO4/c1-7(11(12)13)4-8-2-3-9-10(5-8)15-6-14-9/h2-5H,6H2,1H3/b7-4+
SMILES Code: C/C([N+]([O-])=O)=C\C1=CC=C(OCO2)C2=C1
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 207.19 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Laporte AN, Ji JX, Ma L, Nielsen TO, Brodin BA. Identification of cytotoxic agents disrupting synovial sarcoma oncoprotein interactions by proximity ligation assay. Oncotarget. 2016;7(23):34384-34394. doi:10.18632/oncotarget.8882.